Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts – the CONFIDENCE study protocol

Peer Review reports

Original Submission
25 Jul 2019	Submitted	Original manuscript
22 Dec 2019	Reviewed	Reviewer Report - Melinda Magyari
23 Dec 2019	Reviewed	Reviewer Report - Diane Cookfair
29 Jan 2020	Author responded	Author comments - Petra Dirks
7 Feb 2020	Reviewed	Reviewer Report - Melinda Magyari
17 Feb 2020	Reviewed	Reviewer Report - Diane Cookfair
26 Feb 2020	Author responded	Author comments - Petra Dirks
Resubmission - Version 2
29 Jan 2020	Submitted	Manuscript version 2
Publishing
28 Feb 2020	Editorially accepted
14 Mar 2020	Article published	10.1186/s12883-020-01667-7

Back to article page